MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BTG plc Company Profile (LON:BTG)

Consensus Ratings for BTG plc (LON:BTG) (?)
Ratings Breakdown: 3 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: GBX 757.44

Analysts' Ratings History for BTG plc (LON:BTG)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Jefferies GroupBoost Price TargetBuyGBX 840 -> GBX 860View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Numis Securities LtdReiterated RatingHoldGBX 654View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Deutsche BankReiterated RatingBuyGBX 740View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016RBC CapitalBoost Price TargetOutperformGBX 820 -> GBX 890View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Panmure GordonReiterated RatingBuyGBX 800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015FinnCapReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015InvestecReiterated RatingBuyGBX 1,135 -> GBX 961View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2015N+1 SingerUpgradeBuyGBX 769View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015Bank of AmericaReiterated RatingNeutralGBX 840View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Peel HuntReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for BTG plc (LON:BTG)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for BTG plc (LON:BTG)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for BTG plc (LON:BTG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BTG plc (LON:BTG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2015Rolf SoderstromInsiderSell35,225GBX 704.88£248,293.98Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BTG plc (LON:BTG)
DateHeadline
06/29/16 11:18 AMBTG : *JEFFERIES RAISES BTG PRICE TARGET TO 860 (840) PENCE - 'BUY'
06/29/16 11:18 AMBTG PLC (LON:BTG) target price upped to GBX860 as covered today by Jefferies International
06/28/16 11:20 AMHow Has Britain’s Decision Affected Precious Metals? -
06/27/16 02:38 PMDeutsche Bank Reaffirms "Buy" Rating for BTG PLC (LON:BTG) Stock - Press Telegraph
06/26/16 08:10 AMNumis Gives BTG PLC Price Target With Potential 3.97% Upside - FTSE News
06/24/16 03:03 PMBTG PLC (LON:BTG) price target held steady to GBX740 as reported today by Deutsche Bank
06/23/16 04:32 PMBuyer beware: How the Ontario Teachers’ Pension Plan got caught in the fallout of Brazil’s biggest scandal
06/22/16 08:16 PMWhy ARM Holdings plc, BTG plc and Tasty Plc could soar higher post-EU referendum - Motley Fool UK
06/22/16 04:40 AMWhy ARM Holdings plc, BTG plc and Tasty Plc could soar higher post-EU referendum -
06/17/16 03:12 PMBTG Plc : Relatively good pick today? -
06/16/16 02:58 PMBTG PLC (LON:BTG) Receives 'Buy' Rating From Brokers At Deutsche Bank - FTSE News
06/16/16 07:22 AMBTG PLC (LON:BTG) target price held steady to GBX740 as issued in a report today by Deutsche Bank - Breaking Finance News
06/15/16 03:03 PMBTG completes acquisition of Galil Medical
06/15/16 03:03 PMBTG : Completes the Acquisition of Galil Medical
06/15/16 07:48 AMBTG plc 13.5% Potential Upside Indicated by Deutsche Bank - DirectorsTalk Interviews
06/15/16 01:09 AMCompletes the Acquisition of Galil Medical - [at noodls] - London, UK, 15 June 2016:BTG plc (LSE: BTG), the specialist healthcare company, is pleased to announce that it has completed the acquisition of Galil Medical, a leading provider of cryoablation products ...
06/07/16 04:29 PMETF’s with exposure to BTG Plc : June 7, 2016 -
06/04/16 02:58 PMJPMorgan Chase & Co. Reiterates Neutral Rating for BTG plc (BTG) - Let Me Know About This
06/04/16 11:32 AMWhy GlaxoSmithKline plc and BTG plc are the perfect prescription for growth and income! - Motley Fool UK
06/03/16 11:35 AMBTG plc (BTG) – Investment Analysts' Recent Ratings Updates - Let Me Know About This
06/03/16 11:35 AMWhy GlaxoSmithKline plc and BTG plc are the perfect prescription for growth and income! - Yahoo Finance UK
06/02/16 11:44 AMJP Morgan Cazenove reiterated BTG PLC (LON:BTG) as 'Neutral' With 800 PT - FTSE News - FTSE NewsJP Morgan Cazenove reiterated BTG PLC (LON:BTG) as 'Neutral' With 800 PTFTSE NewsBTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from ...and more »
06/01/16 11:33 AMBTG plc 17.8% Potential Upside Indicated by JP Morgan Cazenove - DirectorsTalk Interviews - Franklin IndependentBTG plc 17.8% Potential Upside Indicated by JP Morgan CazenoveDirectorsTalk InterviewsBTG plc with EPIC/TICKER LON:BTG has had its stock rating noted as 'Reiterates' with the recommendation being set at 'NEUTRAL' this morning by analysts at JP Morgan Cazenove. BTG plc are listed in the Health Care sector within UK Main Market.Analysts at JP Morgan Cazenove Reiterated their Neutral rating for BTG PLC (LON:BTG) with GBX 800.00 PTFranklin IndependentBTG plc (BTG) Stock Rating Reaffirmed by JPMorgan Chase & Co.The Cerbat GemShares Of BTG PLC (LON:BTG) Rated As Neutral By Analysts At JP Morgan CazenoveRisers & FallersShare Trading News -Let Me Know About Thisall 382 news articles »
05/31/16 08:05 AMMiners Are Trending Lower, Technicals Remain Weak -
05/30/16 09:11 PMBTG plc (BTG) Earns “Neutral” Rating from JPMorgan Chase & Co. - Let Me Know About This - BTG plc (BTG) Earns “Neutral” Rating from JPMorgan Chase & Co.Let Me Know About ThisBTG plc logo BTG plc (LON:BTG)'s stock had its “neutral” rating restated by investment analysts at JPMorgan Chase & Co. in a report released on Monday. A number of other equities analysts have also commented on BTG. Numis Securities Ltd reissued a ...and more »
05/30/16 09:11 PMBTG plc (BTG) Earns “Neutral” Rating from JPMorgan Chase & Co. - Let Me Know About This - BTG plc (BTG) Earns “Neutral” Rating from JPMorgan Chase & Co.Let Me Know About ThisBTG plc logo BTG plc (LON:BTG)'s stock had its “neutral” rating restated by investment analysts at JPMorgan Chase & Co. in a report released on Monday. A number of other equities analysts have also commented on BTG. Numis Securities Ltd reissued a ...and more »
05/28/16 01:20 PMBe Prepared for the Outdoors with SnakeBite911™ - The Essential Complement to Your First Aid Kit - PR Newswire (press release) - PR Newswire (press release)Be Prepared for the Outdoors with SnakeBite911™ - The Essential Complement to Your First Aid KitPR Newswire (press release)WEST CONSHOHOCKEN, Pa., May 27, 2016 /PRNewswire/ -- BTG plc (LSE:BTG), an international specialist healthcare company, today announced the launch of SnakeBite911™, the company's free and informative app available for download on the App ...and more »
05/27/16 08:00 AMBe Prepared for the Outdoors with SnakeBite911™ - The Essential Complement to Your First Aid Kit -
05/26/16 09:57 AMNew study highlights potential cost savings when using yttrium-90 glass microspheres for treatment of hepatocellular carcinoma - [at noodls] - TARE (transarterial radio-embolization) using yttrium-90 glass microspheres, associated with both cost savings and overall decreased use of hospital resource WASHINGTON D.C., US: BTG plc (LSE: BTG), an ...
05/24/16 01:56 PMETF’s with exposure to BTG Plc : May 24, 2016 -
05/19/16 03:37 AMBTG Plc breached its 50 day moving average in a Bullish Manner : BTG-GB : May 19, 2016 -
05/17/16 06:07 AMFull Year 2016 BTG PLC Earnings Release - Before Market Open -
05/17/16 03:35 AMRevenue jump boosts BTG full-year profits -
05/06/16 05:00 AMBTG buys Galil Medical for inital £58.3 -
05/06/16 03:14 AMBTG plc acquires Galil Medical, a leader in cryoablation - [at noodls] - Builds on BTG's leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation market Galil Medical is a leader in cryoablation of kidney cancer with significant ...
04/27/16 03:40 AMAre Vodafone Group plc and BTG plc riskier than National Grid plc? -
04/21/16 04:59 PMBTG Plc – Value Analysis (LONDON:BTG) : April 21, 2016 -
04/21/16 04:22 PMETF’s with exposure to BTG Plc : April 21, 2016 -
04/20/16 03:39 AMBTG Plc breached its 50 day moving average in a Bearish Manner : BTG-GB : April 20, 2016 -
04/09/16 01:34 PMBTG to initiate TARGET study of microsphere therapy for HCC - Healio - BTG to initiate TARGET study of microsphere therapy for HCCHealioThe primary endpoint of the study will determine the correlation between the normal tissue absorbed dose, based on 99mTc-MAA, and hyperbilirubinemia grade 3 or greater, for patients administered TheraSphere (BTG Plc). Secondary endpoints in the ...
04/09/16 01:34 PMDeutsche Bank Gives BTG PLC Price Target With Potential 21.19% Upside - FTSE News - FTSE NewsDeutsche Bank Gives BTG PLC Price Target With Potential 21.19% UpsideFTSE NewsDeutsche Bank gave the share price of BTG PLC a price target of 755 meaning the broker expects a potential upside of 21.19% from BTG PLC's current market price of 623. BTG PLC has 382,299,000 shares outstanding at the moment which are trading ...
04/05/16 03:07 AMBTG exudes confidence ahead of final reuslts -
04/05/16 01:24 AMBTG plc: close period update - [at noodls] - London, UK, 5 April, 2016: BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2016 ahead of the publication of its Final Results on 17 May 2016. ...
04/02/16 04:36 AMBTG to Initiate Multi-Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellular Carcinoma - [at noodls] - BTG plc (LSE: BTG), a global specialist healthcare company, today announced plans to initiate the TheraSphere Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment ...
03/10/16 06:53 AMBTG International Canada Expands Operations To Directly Sell Interventional Oncology Products - [CNW Group] - BTG International Canada Expands Operations To Directly Sell Interventional Oncology Products
03/09/16 11:00 AMNew Data from Largest Prospective Study on CroFab® for Treatment of Copperhead Snake Envenomation -
02/28/16 01:23 PMWere Analysts Bullish BTG plc (LON:BTG) This Week? - Franklin Independent - Were Analysts Bullish BTG plc (LON:BTG) This Week?Franklin IndependentOut of 8 analysts covering BTG PLC (LON:BTG), 5 rate it “Buy”, 0 “Sell”, while 3 “Hold”. This means 63% are positive. BTG PLC was the topic in 33 analyst reports since August 6, 2015 according to StockzIntelligence Inc. Below is a list of BTG plc (LON ...and more »
02/26/16 08:35 AMIs BTG PLC (LON:BTG) a Buy or a Sell? Learn What Cantor Fitzgerald Thinks - Franklin Independent - Franklin IndependentIs BTG PLC (LON:BTG) a Buy or a Sell? Learn What Cantor Fitzgerald ThinksFranklin IndependentCantor Fitzgerald analyst has begun coverage with a “Buy” rating on BTG PLC (LON:BTG) today and set a price target of GBX 800.00. The firm's shares opened today at 623. Out of 7 analysts covering BTG PLC (LON:BTG), 4 rate it “Buy”, 0 “Sell”, while 3 ...
02/10/16 09:21 AMAre Gold Gains Temporary? Investors Keep an Eye on the Fed -
02/10/16 06:33 AM'These small firms will grow despite the turmoil': table-topping managers on the stocks they are buying now -
About BTG plc

BTG plc logoBTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company's Interventional Medicine segment offers a portfolio of interventional medicine products that are designed to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins. The Company's Specialty Pharmaceuticals segment offers a portfolio of antidote products that alleviate toxicity and treat rare conditions. The Company's Licensing segment receives royalties relating to the sales of products that are subject to intellectual property and license agreements between the Company and various partners. The Company's subsidiaries include BTG International (Holdings) Ltd, Provensis Ltd, BTG International Ltd and BTG Employee Share Schemes Ltd, among others.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: BTG
  • CUSIP:
Key Metrics:
  • Previous Close: $8.88
  • 50 Day Moving Average: $647.59
  • 200 Day Moving Average: $626.73
  • P/E Ratio: 45.06
  • P/E Growth: 0.00
  • Market Cap: $2.69B
  • Current Quarter EPS Consensus Estimate: $nan EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha